This inventor holds 9 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 2 EPO patents. Top assignee: Takeda Pharmaceutical Company Limited. Active years: 2012-2019.
Location History:
- Osaka, JP (2012)
- Fujisawa, JP (2018)
- Kanagawa, JP (2016 - 2019)
Company Filing History:
Years Active: 2012-2019
Title: Michiko Tawada: Innovator in Pharmaceutical Chemistry
Introduction
Michiko Tawada is a prominent inventor based in Kanagawa, Japan. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that have potential therapeutic applications.
Latest Patents
Tawada holds 9 patents, showcasing her innovative work. Her latest patents include a bicyclic compound that exhibits an acetyl-CoA carboxylase inhibitory action. This compound is useful for the prophylaxis or treatment of cancer and inflammatory diseases, demonstrating superior efficacy. Additionally, she has developed a monocyclic compound that may serve as an agent for the prophylaxis or treatment of cancer, hepatitis, hepatic fibrosis, and fatty liver.
Career Highlights
Tawada is currently associated with Takeda Pharmaceutical Company Limited, where she continues to advance her research and development efforts. Her work has been instrumental in creating new therapeutic options for various diseases.
Collaborations
Throughout her career, Tawada has collaborated with notable colleagues, including Yoshiyuki Fukase and Satoshi Yamamoto. These collaborations have further enriched her research and contributed to her success in the field.
Conclusion
Michiko Tawada's innovative contributions to pharmaceutical chemistry highlight her role as a leading inventor. Her work continues to pave the way for new treatments and advancements in healthcare.